Symphogen is a biotechnology company based in Copenhagen, Denmark. The Company develops recombinant polyclonal antibodies for the prevention and treatment of serious diseases such as infections and cancer.

Antibodies are an important part of the immune system, whose role is to help the body prevent and fight infections and diseases. When a foreign and potentially harmful object (called an “antigen”), such as a bacteria, virus, or cancer cell, is in the human body, antibodies find and then either neutralize or destroy the invader.

The human body produces many different kinds of antibodies that are able to attach themselves to different parts of an antigen, which helps them completely eliminate these foreign objects. This is called a “polyclonal” response, because there is more than one type of antibody involved. The polyclonal antibodies that Symphogen develops therefore mimic the natural human immune response. This means that they may have potential in preventing and treating infections, certain types of cancer, and other diseases.